Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for lung cancer, listed by clinical state.

Clicking a link below will scroll the
page down to the relevant section

Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Lung Adenocarcinoma
Other Lung Cancer Related Trials

Non-Small Cell Lung Cancer

A Phase I Study of PDX (Pralatrexate) Supplemented with Vitamin B12 and Folic Acid in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer
Azzoli, Christopher, MD

[Protocol 04-105]
A Phase I/II Trial of Fixed Doses of Daily Gefitinib with Escalating Doses of Daily RAD001 in Advanced Non-Small Cell Lung Cancer
Miller, Vincent, MD

[Protocol 04-033]
A Phase II Study of Erlotinib and Chemotherapy for Operable Stage IB-IIIA Non-Small Cell Lung Cancer Patients Who Are Nonsmokers or Light Smokers
Rizvi, Naiyer, MD

[Protocol 07-103]
A Phase II Study of XL647 in Subjects with Non Small-Cell Lung Cancer
Rizvi, Naiyer, MD

[Protocol 06-099]
A Phase II Trial to Correlate Response to Gefitinib with Mutations in the EGFR Gene in Patients with Non-Small Cell Lung Cancer
Rizvi, Naiyer, MD

[Protocol 04-071]
A Phase IIIb Trial Comparing Bevacizumab Therapy with/without Erlotinib After Completion of Chemotherapy with Bevacizumab for the First-Line Treatment of Locally Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer
Miller, Vincent, MD

[Protocol 06-098]
A Pilot Trial Assessing the Safety and Immunogenicity of the GI-4000 Vaccine as Consolidation Therapy after Curative Treatment for Stage I-III Non-Small Cell Lung Cancers with K-ras Mutations
Azzoli, Christopher, MD

[Protocol 07-149]
A Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients with Thoracic and Myeloid Neoplasms
Krug, Lee, MD

[Protocol 06-085]
Multimodality Treatment for Patients with Resectable Non-Small Cell Lung Cancer (BEACON Study: BEvacizumab And Chemotherapy for Operable NSCLC)
Rizvi, Naiyer, MD

[Protocol 05-052]

Top

Small Cell Lung Cancer

A Phase I/II Study of Cisplatin, Etoposide, and Sunitinib for Untreated Advanced Small Cell Lung Cancer
Krug, Lee, MD

[Protocol 07-106]
A Phase I/II Study of Obatoclax Mesylate (GX15-070MS) Plus Topotecan in Patients with Relapsed Small Cell Lung Carcinoma
Krug, Lee, MD

[Protocol 07-082]

Top

Lung Adenocarcinoma

A Phase II Study of Erlotinib (Tarceva^®) With or Without Carboplatin/Paclitaxel in Patients with Untreated Lung Adenocarcinoma Who Never Smoked or Were Former Light Smokers
Miller, Vincent, MD

[Protocol 05-127]
A Phase II Trial of Dasatinib in Patients with Lung Adenocarcinoma with Acquired Resistance to Erlotinib or Gefitinib
Miller, Vincent, MD

[Protocol 06-143]

Top

Other Lung Cancer Related Trials

Improving Functional Outcomes in Patients with Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging
Kraus, Dennis, MD

[Protocol 05-036]
Lung Cancer Informational Study (LCIS)
Tyson, Leslie, MSN, NP

[Protocol 06-141]
Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer
Azzoli, Christopher, MD

[Protocol 02-111]
Methylated Genes in Blood as Biomarkers for Early-Stage Non-Small Cell Lung Cancer
Rusch, Valerie, MD

[Protocol 02-112]
Physical Activity and Inactivity in Lung Cancer Survivors
Ostroff, Jamie, PhD

[Protocol 05-094]
Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Lobectomy versus Thoracotomy and Lobectomy
Park, Bernard, MD

[Protocol 05-006]
Quality of Life in Lung Cancer Survivors
Ostroff, Jamie, PhD

[Protocol 05-057]
Screening for Depression in Lung Cancer Patients
Passik, Steven, PhD

[Protocol 06-038]
The Use of Breathing Synchronized PET/CT Imaging in the Detection and Quantification of FDG Uptake in Lung Nodules
Schoder, Heiko, MD

[Protocol 04-025]

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2008 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org